Liquid Biopsy with Emphasis on NIPT Marks Dawn of a New Era

Posted by Deeksha on May 23rd, 2019

Tissue biopsies have proved their mettle in medical practices as a means of diagnosing cancer and other diseases. Liquid biopsy has freshly forayed into clinical practice as a robust and relatively straightforward process which often comprises of a simple blood draw, amplification of the molecular targets to facilitate the assessment of the defined biomarkers and extraction of nucleic acid from the blood plasma have grown in popularity. In the present context, liquid biopsy in clinical diagnostic practice is highly sought after in non-invasive prenatal testing (NIPT), alluding disorders such as cystic fibrosis and trisomy 21 can be identified without an invasive amniocentesis that can be detrimental to the baby. These actionable insights are according to the report title, “Liquid Biopsy with Emphasis on NIPT: Global Markets to 2023,” which has been of late added to Market Research Hub’s (MRH) ever-expanding repository. The ongoing research is underscoring the immense potentiality of liquid biopsy technology in NIPT. Pregnancy is a reproducible physiological process with minor differences and starting from week 9 of pregnancy, the rate of fetal DNA in the mother’s circulation is comparatively high at 10 percent. NIPT covers chromosomal disorders such as Trisomy 18 (Edwards’s syndrome); Trisomy 21 (Down syndrome) and Trisomy 13 (Patau syndrome). Next-Generation Sequencing (NGS) technology has been the secret sauce in both liquid biopsy and NIPT. Liquid biopsy is being used to identify single nucleotide variants (SNVs) or copy number aberrations.

Get Sample Copy of this Report@ https://www.marketresearchhub.com/enquiry.php?type=S&repid=2319850

Liquid Biopsy with Emphasis on NIPT: Report Content

The report provides a robust analysis on the liquid biopsy with emphasis on NIPT that is underpinned by quantitative and qualitative analysis. Besides, the report throws light on the dynamics in the market which have bearing on the growth of the liquid biopsy with emphasis on NIPT, incorporating drivers, trends, restraints, and opportunities. In addition, the report also delineates segmentation to showcases a comprehensive analysis of the liquid biopsy with emphasis on NIPT.

The report also focuses on executive summary and overview section, delineating an exhaustive analysis of the liquid biopsy with emphasis on NIPT. In addition, the overview section sheds light into value chain analysis, supply chain and pricing analysis and PESTLE analysis to reveal a comprehensive analysis on the liquid biopsy with emphasis on NIPT. Besides, the overview section also throws light on Porters’ Five Force analysis that is known to aid in assessing competitive landscape with respect to liquid biopsy with emphasis on NIPT. The report does the benchmarking to compare the performance of the business products and processes with the best performances of other companies both inside and outside the industry in quest for superior performance.

The comprehensive assessment of the competitive landscape of the liquid biopsy with emphasis on NIPT hinges on Porters’ Five Force Analysis. In addition, the Porters’ Five Force Analysis delineates the strategies of the leading players in the liquid biopsy with emphasis on NIPT. The in-depth analysis of the pertinent players and their business strategies are propelled by SWOT analysis, company profile, product portfolio and recent development.

Request TOC of the Report @ https://www.marketresearchhub.com/report/liquid-biopsy-with-emphasis-on-nipt-global-markets-to-2023-report.html

Liquid Biopsy with Emphasis on NIPT: Research Methodology

The report is the result of unbiased and authentic primary sources and secondary sources that present a deep dive analysis on liquid biopsy with emphasis on NIPT. The secondary research hinges on Factiva, resourceful database, EC filing and trade journals. On the other side, the report has also heavily relied upon primary research, that includes genuine analysis from pundits, veracious and unbiased assessment from seasoned analyst, and surveys and telephonic interview.